Featured Posts
News Release
FDA deserves credit for approval pancreatic cancer drug
The FDA on August 26 approved a new breakthrough drug to treat pancreatic cancer. CEI Senior Fellow and Economist Jeremy Nighohossian praised…
Blog
Fauci’s lasting legacy will be the damage he did to science and government
Anthony Fauci isn’t faring well in the court of public opinion. His recently divulged “diary” and subsequent July 29 appearance before the Senate Homeland…
News Release
FDA commissioner resignation opens opportunity for refocus on science over politics
After a somewhat tumultuous tenure, FDA commissioner Marty Makary is stepping down. While Dr. Makary made his mission to accelerate drug approval and bring…
Search Posts
Newsletter
Voter Fraud, Health Care Reforms and Latin American Politics
Competing legal teams prepare to do battle over allegations of voter fraud. A new report contrasts the competing health care plans announced by the major…
Newsletter
Bailout Fallout, the New (Green) Deal and Scaring Parents with Toxic Arguments
The House and Senate agree on a $700 billion financial bailout bill. Environmentalists try to leverage the mortgage and Wall Street financial crisis to argue…
Citation
the presidential candidates’ views on the biotech industry
Citation
FDA approval for “biogeneric” drugs
Newsletter
Hurricane Recovery, Union Politics and Disaster Insurance
Residents of the hurricane-ravaged Gulf Coast are being advised to avoid taps and drink only bottled water. Unions increase their spending on campaign advertisements and…
Op-Eds
Activists Hit the (Plastic) Bottle Again
Anti-chemical activists opened a new front in their jihad against the plastics chemical bisphenol-A (BPA) this week.